Eli Lilly Seeks FDA Approval for Rheumatoid-Arthritis Drug

Eli Lilly Seeks FDA Approval for Rheumatoid-Arthritis Drug

Eli Lilly & Co. on Tuesday said it filed a new drug application with the U.S. Food and Drug Administration for an oral rheumatoid-arthritis treatment, and the pharmaceutical company affirmed its earnings guidance for the year. Lilly, which is joining

(Visited 4 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.